Citation Tools
PDFCase report
Low-intermediate dose of lenvatinib in anaplastic thyroid cancer is highly effective and safe
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Low-intermediate dose of lenvatinib in anaplastic thyroid cancer is highly effective and safe